Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction
Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction
Recruiting · NCT07172659 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction | Erythema Nodosum Leprosum | Recruiting | Phase 2 | 2026-10-06 | NCT07172659 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medicines Development for Global Health | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre de Dépistage de Traitement de la Lèpre et de l'Ulcère de Burulli | Abomey-Calavi | Benin | 1 |
| Chr de Divo | Divo | Côte d’Ivoire | 1 |
| Harborview Medical Center, University of Washington | Seattle | United States | 1 |
| Philippine General Hospital, University of the Philippines, Manila | Manila | Philippines | 1 |
| Programme national lutte contre la lèpre | Tôlanaro | Madagascar | 1 |
| Universitas Gadjah Mada | Yogyakarta | Indonesia | 1 |